Revamped and revitalized from Biopharma Asia Convention, Phar-East will be exploring 11 of the most exciting pharma areas in Asia: immunotherapy, vaccines, precision medicine, cell & gene therapy, biodata, orphan drugs, partnering, commercialization & market access, antibodies, biosimilars and biotech innovations. In the past, the event has drawn over 22,000 attendees over its first 9 years from all over the world. As Asia’s global life sciences portfolio and biotech hubs continue to grow, Phar East anticipates showcasing the very best in Asian pharma.

“This is our first year attending the Phar-East conference; I look forward to educating attendee’s on our robust software and give a better understanding of what separates us from our competitors,” said Al Campbell, vice president, strategic alliances and director, business development.

DSG invites attendees to meet with Al Campbell, and Ricky Brohmer, vice president of Asia operations, who will be available at booth G08 to demonstrate our eCaselink™ EDC software, and its complete line of integrated solutions.

To request a meeting or find upcoming events and conferences DSG will be attending, please visit: http://dsg-us.com/dsg-events.html.

About DSG

DSG is a founder of the eClinical industry and through its innovative technology helped shape the current eClinical landscape. Its solutions support the development of life saving drugs and therapies and DSG was one of the first companies to deploy proprietary eClinical products. DSG’s suite of award-winning solutions includes its flagship eCaseLink™ EDC, Risk-Based Monitoring, eSource, ePRO, IRT Randomization and Trial Supply Management, Drug Safety System, and CTMS. Founded in 1992, the company is proud to be recognized as the first provider of a fully integrated EDC and IRT Randomization and Clinical Supply System with the SCDM Data Driven Innovation Award. For more information, please visit www.dsg-us.com.